All Stories

  1. Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus
  2. The Amyloid Cascade Hypothesis in Alzheimer’s Disease: It’s Time to Change Our Mind
  3. Amyloid β: Walking on the dark side of the moon
  4. PDE4D and memory
  5. Synthesis, biological activities and pharmacokinetic properties of new fluorinated derivatives of selective PDE4D inhibitors
  6. Exocytosis regulates trafficking of GABA and glycine heterotransporters in spinal cord glutamatergic synapses: a mechanism for the excessive heterotransporter-induced release of glutamate in experimental amyotrophic lateral sclerosis
  7. PDE4D inhibitors: A potential strategy for the treatment of memory impairment?
  8. Synthesis, Biological Evaluation, and Molecular Modeling of New 3-(Cyclopentyloxy)-4-methoxybenzaldehyde O -(2-(2,6-Dimethylmorpholino)-2-oxoethyl) Oxime (GEBR-7b) Related Phosphodiesterase 4D (PDE4D) Inhibitors
  9. A PHYSIOLOGICAL ROLE FOR AMYLOID BETA IN CYCLIC AMP-STIMULATED LONG TERM POTENTIATION
  10. LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex
  11. A novel mechanism for cyclic adenosine monophosphate-mediated memory formation: Role of amyloid beta
  12. Neuropeptide S inhibits release of 5-HT and glycine in mouse amygdala and frontal/prefrontal cortex through activation of the neuropeptide S receptor
  13. Cyclic adenosine monophosphate as an endogenous modulator of the amyloid-β precursor protein metabolism
  14. Letter to the Editor
  15. Presynaptic Nicotinic α7 and Non-α7 Receptors Stimulate Endogenous GABA Release from Rat Hippocampal Synaptosomes through Two Mechanisms of Action
  16. Reduced GABA Content in the Motor Thalamus during Effective Deep Brain Stimulation of the Subthalamic Nucleus
  17. Alterations of glutamate release in the spinal cord of mice with experimental autoimmune encephalomyelitis
  18. The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway
  19. l-Aspartate as an amino acid neurotransmitter: mechanisms of the depolarization-induced release from cerebrocortical synaptosomes
  20. Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease
  21. In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
  22. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by ‘pathologically’ elevated extraterminal K+concentrations
  23. Biochemical and electrophysiological changes of substantia nigra pars reticulata driven by subthalamic stimulation in patients with Parkinson's disease
  24. Cyclo-oxygenase-1 and -2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N-methyl-d-aspartate receptors in rat hippocampus
  25. Subthalamic stimulation activates internal pallidus: Evidence from cGMP microdialysis in PD patients
  26. The NOS/sGC pathway in the rat central nervous system: a microdialysis overview
  27. Glutamate-mediated overexpression of CD38 in astrocytes cultured with neurones
  28. Effects of phosphodiesterase inhibition on cortical spreading depression and associated changes in extracellular cyclic GMP
  29. GABAA, but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex
  30. Benzodiazepine-Sensitive GABAA Receptors Limit the Activity of the NMDA/NO/Cyclic GMP Pathway
  31. Dbs in Parkinsonian Subthalamic Nucleus: Electrophysiological and Biochemical Changes
  32. Helicobacter pylori‐induced reduction of acute levodopa absorption in parkinson's disease patients
  33. Evidence of a role for cyclic ADP-ribose in calcium signalling and neurotransmitter release in cultured astrocytes
  34. Microdialysis in Parkinsonian Patient Basal Ganglia: Acute Apomorphine-Induced Clinical and Electrophysiological Effects Not Paralleled by Changes in the Release of Neuroactive Amino Acids
  35. Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype
  36. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway
  37. Intracerebral administration of l-kynurenine decreases N-methyl-d-aspartate receptor-mediated production of cGMP in the cerebellum and hippocampus of unanaesthetized rats subjected to transcerebral microdialysis
  38. Nicotine administration stimulates the in vivo N-methyl-D -aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release
  39. Activation of brain nitric oxide synthase in depolarized human temporal cortex slices: differential role of voltage-sensitive calcium channels
  40. In vivo microdialysis study of GABAA and GABaB receptors modulating the glutamate receptor/NO/ cyclic GMP pathway in the rat hippocampus
  41. The glutamate receptor/no/cyclic gmp pathway in the hippocampus of freely moving rats: Modulation by cyclothiazide, interaction with gaba and the behavioural consequences
  42. D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis
  43. Ectocellular in vitro and in vivo metabolism of cADP-ribose in cerebellum
  44. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway
  45. Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum
  46. MRI postoperative monitoring in patients surgically treated for aortic dissection
  47. Heterocarrier-mediated reciprocal modulation of glutamate and glycine release in rat cerebral cortex and spinal cord synaptosomes
  48. Evaluation of the mechanisms underlying the kainate-induced impairment of [3H]dopamine release in the rat striatum
  49. Autoradiographical evaluation of [3H]glycine uptake in rat forebrain: Cellular localization in the hippocampus
  50. Release-regulating dopamine autoreceptors in human cerebral cortex
  51. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine
  52. Dopamine release and dopaminergic inhibition of acetylcholine release in rat striatal slices after nigro-striatal hemitransection and parenteral ganglioside administration
  53. [3H]Glycine uptake in rat hippocampus: kinetic analysis and autoradiographic localization
  54. Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra
  55. Glycine enhances [3H]noradrenaline release from slices of rat hippocampus
  56. Glycine stimulates [3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus
  57. Acetylcholine release from rat hippocampal slices is modulated by 5-hydroxytryptamine
  58. Presynaptic Mechanisms Underlying the ?-Aminobutyric Acid-Evoked Receptor-Independent Release of [3H]Norepinephrine in Rat Hippocampus
  59. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection
  60. Biochemical Markers of DBS-Induced Transition from “Off” to “On” State in Parkinsonian Patients